October 15, 2018
We will be presenting our research towards a new treatment for Giloblastoma Multiforme. Come see us at 11:05 in Auditorium 1.
Hemispherian Oncology, was selected to pitch at the DNB Healthcare Conference. Dr. Adam Robertson provided an excellent overview of our company’s goal; advancing a glioblastoma multiforme treatment that we discovered. This disorder has one of the highest unmet needs in oncology.
The DNB Healthcare Conference highlighted many excellent Norwegian companies. It was an honor to be among the companies selected to present. Prior to the event DNB provided all the presenters with complementary coaching sessions.